The latter likely reflects the inconvenience of breeding transgenic disease-model mice lacking Nrf2, but such mice have been reported for both Alzheimer’s disease [15] and amyotrophic lateral sclerosis [159,161,162] models. Here, NFE2L2 is linked to early-onset autosomal dominant Alzheimer disease.